Browse by Publisher
Browse by Region

Industry Reports >> Pharmaceuticals and Healthcare

Browse the latest reports in the pharmaceuticals and healthcare industry below. You can sort your results by publication date, by price or alphabetically

Sort By:
Report Status:
26911 Report Results
Page 1 of 1077
Go To Page:
    
  Go

Insulin Resistance - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2017’, provides an overview of the Insulin Resistance pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insulin Resistance, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological a.....

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2017’, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The r.....

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molec.....

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report als.....

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017’, provides an overview of the Opioid-Induced Constipation (OIC) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report .....

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017’, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA.....

Hypotension - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Hypotension - Pipeline Review, H1 2017’, provides an overview of the Hypotension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypotension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeu.....

Encephalitis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Encephalitis - Pipeline Review, H1 2017’, provides an overview of the Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the thera.....

Cluster Headache Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Cluster Headache Syndrome - Pipeline Review, H1 2017’, provides an overview of the Cluster Headache Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cluster Headache Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descript.....

Complex Regional Pain Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H1 2017’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Complex Regional Pain Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also cove.....

Drug Addiction - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H1 2017’, provides an overview of the Drug Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Drug Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the.....

Skin And Soft Tissue Infections - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Skin And Soft Tissue Infections - Pipeline Review, H1 2017’, provides an overview of the Skin And Soft Tissue Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Skin And Soft Tissue Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also c.....

Pressure Ulcers - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Pressure Ulcers - Pipeline Review, H1 2017’, provides an overview of the Pressure Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pressure Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of .....

Nasal Polyposis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Nasal Polyposis - Pipeline Review, H1 2017’, provides an overview of the Nasal Polyposis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nasal Polyposis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of .....

Crigler-Najjar Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2017’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Crigler-Najjar Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ph.....

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H1 2017’, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sandhoff Disease (Jatzkewitz-Pilz Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) .....

Familial Adenomatous Polyposis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Familial Adenomatous Polyposis - Pipeline Review, H1 2017’, provides an overview of the Familial Adenomatous Polyposis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Familial Adenomatous Polyposis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also cove.....

Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017’, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gorlin Syndrome (Basal Cell Nevus Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) .....

Osteogenesis Imperfecta - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Osteogenesis Imperfecta - Pipeline Review, H1 2017’, provides an overview of the Osteogenesis Imperfecta pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteogenesis Imperfecta, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ph.....

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2017’, provides an overview of the Primary Immune Deficiency (PID) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Primary Immune Deficiency (PID), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also c.....

Primary Hyperoxaluria - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Primary Hyperoxaluria - Pipeline Review, H1 2017’, provides an overview of the Primary Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmaco.....

Contrast Induced Nephropathy - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Contrast Induced Nephropathy - Pipeline Review, H1 2017’, provides an overview of the Contrast Induced Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the.....

Hemorrhage - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Hemorrhage - Pipeline Review, H1 2017’, provides an overview of the Hemorrhage pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemorrhage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutic.....

Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2017’, provides an overview of the Granulomatosis with Polyangiitis (Wegener Polyangiitis) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Granulomatosis with Polyangiitis (Wegener Polyangiitis), complete with analysis by stage of development, drug target, mechanism of action (.....

Ragweed Pollen Allergy - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Ragweed Pollen Allergy - Pipeline Review, H1 2017’, provides an overview of the Ragweed Pollen Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharm.....